State of Wisconsin Investment Board’s Lyell Immunopharma LYEL Stock Holding History

State of Wisconsin Investment Board’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-665	Closed	-$18.4K	–	2330
2024 Q3	$18.4K	Sell	665 -3,843	-85%	-$113K	﹤0.01%	2265
2024 Q2	$131K	Sell	4,508 -120	-3%	-$5.71K	﹤0.01%	2205
2024 Q1	$206K	Sell	4,628 -551	-11%	-$23.6K	﹤0.01%	2060
2023 Q4	$201K	Sell	5,179 -156	-3%	-$5.62K	﹤0.01%	2200
2023 Q3	$157K	Sell	5,335 -123	-2%	-$5.84K	﹤0.01%	2304
2023 Q2	$347K	Buy	+5,458	New	+$302K	﹤0.01%	1947

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

OPL

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

State of Wisconsin Investment Board's LYEL Position: Q4 2024 in Review

State of Wisconsin Investment Board sold out of Lyell Immunopharma (LYEL) in Q4 2024, closing a stake of 665 shares — an estimated $18.4K sold.

State of Wisconsin Investment Board first reported a position in LYEL in Q2 2023 and held it in 6 quarters. The position peaked at $347K in Q2 2023. 105 funds tracked by Wall St. Rank hold LYEL as of Q4 2024.

State of Wisconsin Investment Board reported no remaining Lyell Immunopharma position as of Q4 2024 after selling out during the quarter.
State of Wisconsin Investment Board sold 665 Lyell Immunopharma shares in Q4 2024, an estimated $18.4K.
State of Wisconsin Investment Board first reported a position in Lyell Immunopharma in Q2 2023 and held it in 6 quarters.
State of Wisconsin Investment Board's Lyell Immunopharma position peaked at $347K in Q2 2023.
105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2024, filed 14 Feb 2025.